Biontech Se Stock Number Of Shares Shorted
| 0A3M Stock | 119.55 0.38 0.32% |
BioNTech SE fundamentals help investors to digest information that contributes to BioNTech's financial success or failures. It also enables traders to predict the movement of BioNTech Stock. The fundamental analysis module provides a way to measure BioNTech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioNTech stock.
BioNTech | Number Of Shares Shorted |
BioNTech SE Company Number Of Shares Shorted Analysis
BioNTech's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, BioNTech SE has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Commercial Services & Supplies sector and about the same as Industrials (which currently averages 0.0) industry. The number of shares shorted for all United Kingdom stocks is 100.0% higher than that of the company.
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
BioNTech Fundamentals
| Return On Equity | -0.024 | |||
| Return On Asset | -0.0124 | |||
| Profit Margin | (0.15) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 12.2 B | |||
| Shares Owned By Insiders | 61.65 % | |||
| Shares Owned By Institutions | 20.64 % | |||
| Revenue | 3.04 B | |||
| Gross Profit | 16.07 B | |||
| EBITDA | (274.5 M) | |||
| Net Income | 9.43 B | |||
| Book Value Per Share | 79.73 X | |||
| Cash Flow From Operations | 889.7 M | |||
| Earnings Per Share | 52.02 X | |||
| Number Of Employees | 6.13 K | |||
| Beta | 0.26 | |||
| Retained Earnings | 9.88 B |
About BioNTech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioNTech SE's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioNTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioNTech SE based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.